Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

DOI Full Paper Access

17

Citations

18

References

2019

Year

John D. Fenwick, David Landau, Angela T. Baker, Andrew Bates, Chinnamani Eswar, Angel Garcia-Alonso, Susan Harden, Marianne Illsley, V. Laurence, Zafar Malik,

International Journal of Radiation Oncology*Biology*Physics

References

	Year	Citations

Page 1